<scp>FDA IDE</scp> validation of multiple myeloma <scp>MRD</scp> test by flow cytometry
Dragan Jevremović(Mayo Clinic in Arizona), Horatiu Olteanu(Mayo Clinic in Arizona), Morie A. Gertz(Medical University of South Carolina), Jiehao Zhou(Indiana University School of Medicine), Shaji Kumar(Mayo Clinic), Min Shi(Mayo Clinic in Arizona), Prashant Kapoor, Linda B. Baughn(Mayo Clinic in Arizona), Moritz Binder(Mayo Clinic in Arizona), Gregory E. Otteson(Mayo Clinic in Arizona), Pedro Horna(Mayo Clinic), S. Vincent Rajkumar(WinnMed), Wilson I. Gonsalves(Mayo Clinic in Arizona), Patricia T. Greipp(Mayo Clinic), Taxiarchis Kourelis(Mayo Clinic in Arizona), Eli Muchtar(Mayo Clinic), Michael Timm(Mayo Clinic), Angela Dispenzieri(Mayo Clinic), Shannon A. Bennett(Mayo Clinic), Francis K. Buadi
Cited by 7
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k